Yingjun Xie

818 total citations
65 papers, 543 citations indexed

About

Yingjun Xie is a scholar working on Molecular Biology, Genetics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Yingjun Xie has authored 65 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 34 papers in Genetics and 13 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Yingjun Xie's work include Genomic variations and chromosomal abnormalities (19 papers), Prenatal Screening and Diagnostics (11 papers) and CRISPR and Genetic Engineering (8 papers). Yingjun Xie is often cited by papers focused on Genomic variations and chromosomal abnormalities (19 papers), Prenatal Screening and Diagnostics (11 papers) and CRISPR and Genetic Engineering (8 papers). Yingjun Xie collaborates with scholars based in China, Hong Kong and Singapore. Yingjun Xie's co-authors include Xiaofang Sun, Bing Song, Ding Wang, Yexing Xian, Zhanhui Ou, Hongning Xie, Linhuan Huang, Yu‐Chang Chen, Diyu Chen and Yi Yang and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and NeuroImage.

In The Last Decade

Yingjun Xie

59 papers receiving 537 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yingjun Xie China 13 279 157 138 128 75 65 543
LaDonna Immken United States 13 372 1.3× 339 2.2× 112 0.8× 115 0.9× 58 0.8× 21 689
Sharan Goobie Canada 15 162 0.6× 281 1.8× 52 0.4× 88 0.7× 55 0.7× 29 504
Jean‐Michel Pedespan France 15 145 0.5× 121 0.8× 197 1.4× 62 0.5× 84 1.1× 34 536
Vinciane Dideberg Belgium 13 145 0.5× 174 1.1× 49 0.4× 77 0.6× 26 0.3× 24 537
Amal Y. Kentab Saudi Arabia 13 443 1.6× 196 1.2× 62 0.4× 30 0.2× 53 0.7× 44 780
Aziza Sbiti Morocco 9 211 0.8× 133 0.8× 71 0.5× 69 0.5× 34 0.5× 19 387
Michela Malacarne Italy 16 282 1.0× 416 2.6× 150 1.1× 47 0.4× 45 0.6× 56 626
Christalena Sofocleous Greece 14 218 0.8× 261 1.7× 81 0.6× 48 0.4× 41 0.5× 45 459
Chantal Missirian France 16 404 1.4× 418 2.7× 100 0.7× 30 0.2× 41 0.5× 39 720
Joy B. Redman United States 17 301 1.1× 203 1.3× 71 0.5× 91 0.7× 119 1.6× 27 781

Countries citing papers authored by Yingjun Xie

Since Specialization
Citations

This map shows the geographic impact of Yingjun Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingjun Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingjun Xie more than expected).

Fields of papers citing papers by Yingjun Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingjun Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingjun Xie. The network helps show where Yingjun Xie may publish in the future.

Co-authorship network of co-authors of Yingjun Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Yingjun Xie. A scholar is included among the top collaborators of Yingjun Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingjun Xie. Yingjun Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, Yuxin, Yingjun Xie, Mingkai Zhang, et al.. (2025). Multimodal integration of plasma biomarkers, MRI, and genetic risk to predict cerebral amyloid burden in Alzheimer’s disease. NeuroImage. 322. 121550–121550.
2.
3.
Yang, Yinghong, et al.. (2024). In situ correction of various β-thalassemia mutations in human hematopoietic stem cells. Frontiers in Cell and Developmental Biology. 11. 1276890–1276890. 3 indexed citations
4.
5.
He, Qiuju, Wen Qi, Zhifa Li, et al.. (2022). Epilepsy Combined With Multiple Gene Heterozygous Mutation. Frontiers in Pediatrics. 10. 763642–763642.
6.
Yang, Yi, Xiangjin Kang, Shiqi Hu, et al.. (2021). CRISPR/Cas9-mediated β-globin gene knockout in rabbits recapitulates human β-thalassemia. Journal of Biological Chemistry. 296. 100464–100464. 9 indexed citations
7.
Zhang, Na, et al.. (2021). Molecular Characterization Analysis of Thalassemia and Hemoglobinopathy in Quanzhou, Southeast China: A Large-Scale Retrospective Study. Frontiers in Genetics. 12. 727233–727233. 10 indexed citations
8.
Wang, Ding, et al.. (2020). Different culture method changing CD105 expression in amniotic fluid MSCs without affecting differentiation ability or immune function. Journal of Cellular and Molecular Medicine. 24(7). 4212–4222. 15 indexed citations
9.
Xian, Yexing, Yingjun Xie, Bing Song, et al.. (2020). The safety and effectiveness of genetically corrected iPSCs derived from β-thalassaemia patients in nonmyeloablative β-thalassaemic mice. Stem Cell Research & Therapy. 11(1). 288–288. 4 indexed citations
10.
Xie, Yingjun, Yi Cheng, Lina He, et al.. (2020). Generation of induced pluripotent stem cell GZHMCi001-A and GZHMCi001-B derived from peripheral blood mononuclear cells of epileptic patients with KCNC1 mutation. Stem Cell Research. 47. 101897–101897. 4 indexed citations
12.
Xie, Yingjun, Yi Yang, Yexing Xian, et al.. (2018). CRISPR/Cas9-Targeted Deletion of Polyglutamine in Spinocerebellar Ataxia Type 3-Derived Induced Pluripotent Stem Cells. Stem Cells and Development. 27(11). 756–770. 52 indexed citations
13.
Xu, Lingling, et al.. (2018). The phenomena of balanced effect between α-globin gene and of β-globin gene. BMC Medical Genetics. 19(1). 145–145. 5 indexed citations
14.
Huang, Xuan, Yingjun Xie, & Qun Fang. (2017). 22q12.3 microduplication overlapping the LARGE gene as a male-only affected loci responsible for increasing the risk of autism spectrum disorder. Biomedical Reports. 7(1). 51–55. 1 indexed citations
15.
He, Jialing, Yingjun Xie, Xiaoman Wang, et al.. (2017). Psychomotor retardation with a 1q42.11–q42.12 deletion. Hereditas. 154(1). 6–6. 4 indexed citations
16.
Xie, Yingjun, et al.. (2016). Paternal Uniparental Disomy of Chromosome 14 with Hypospadias. Cytogenetic and Genome Research. 148(4). 256–261. 5 indexed citations
17.
Lin, Shaobin, Yingjun Xie, Yi Zhou, et al.. (2015). Improved assay performance of single nucleotide polymorphism array over conventional karyotyping in analyzing products of conception. Journal of the Chinese Medical Association. 78(7). 408–413. 14 indexed citations
18.
Xie, Yingjun, Wenyin He, Weiqiang Liu, et al.. (2014). Clinical Outcome: A Monosomy 18p is Better than a Tetrasomy 18p. Cytogenetic and Genome Research. 144(4). 294–298. 3 indexed citations
19.
Xie, Yingjun, et al.. (2014). Microduplication of chromosome Xq25 encompassing STAG2 gene in a boy with intellectual disability. European Journal of Medical Genetics. 58(2). 116–121. 10 indexed citations
20.
Xie, Yingjun, et al.. (2008). [Mechanism of BVT.2733 and pioglitazone in the improvement of insulin resistance].. PubMed. 47(11). 938–41. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026